In vivo evaluation of 5-fluorouracil-containing self-expandable nitinol stent in rabbits: Efficiency in long-term local drug delivery

Journal of Pharmaceutical Sciences

Volumn 99, Issue 7, 2010, Pages 3009-3018

  Guo, Sheng Rong ^a   Wang, Zhong Min ^a,b   Zhang, Ya Qiong ^a   Lei, Lei ^a   Shi, Jing Min ^c   Chen, Ke Min ^a   Yu, Zhang ^d  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

^c SHANGHAI INSTITUTE FOR FOOD AND DRUG CONTROL   (China)

^d FUDAN UNIVERSITY   (China)

Author keywords

Cancer chemotherapy; Controlled release; High performance pressure liquid chromatography (HPLC); Mass spectrometry; Polymeric drug delivery systems; Site specific delivery

Indexed keywords

ETHYLENE VINYL ACETATE COPOLYMER; FLUOROURACIL; NITINOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APPLICATION SITE DESQUAMATION; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG LIVER LEVEL; DRUG MUSCLE LEVEL; DRUG TISSUE LEVEL; ESOPHAGUS; ESOPHAGUS MUCOSA; ESOPHAGUS MUSCLE; ESOPHAGUS STENT; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; LIQUID CHROMATOGRAPHY; MALE; MATERIAL COATING; NONHUMAN; RABBIT; SCANNING ELECTRON MICROSCOPY; STENT; SUSTAINED DRUG RELEASE; TANDEM MASS SPECTROMETRY;

EID: 77953300881     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22066     Document Type: Article

References (33)

1. Griffin SM, Lamb P. 2006. Oesophageal cancer. Surgery 24:97-100.
2. Layke JC, Lopez PP. 2006. Esophageal cancer: A review and update. Am Fam Physician 73:2187-2194.
3. Muller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. 1990. Surgical therapy of esophageal-carcinoma. Br J Surg 77:845-857.
4. Knyrim K, Wagner HJ, Bethge N, Keymling M, Vakil N. 1993. A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. N Engl J Med 329:1302-1307.
5. Sarper A, Oz N, Cihangir C, Demircan A, Isin E. 2003. The efficacy of self-expanding metal stents for palliation of malignant esophageal strictures and fistulas. Eur J Cardiothorac Surg 23:794-798.
6. Johnson E, Enden T, Noreng HJ, Holck-Steen A, Gjerlaug BE, Morken T, Johannessen HO, Drolsum A. 2006. Survival and complications after insertion of self-expandable metal stents for malignant oesophageal stenosis. Scand J Gastroenterol 41: 252-256.
7. Saxon RR, Morrison KE, Lakin PC, Petersen BD, Barton RE, Katon RM, Keller FS. 1997. Malignant esophageal obstruction and esophagorespiratory fistula: Palliation with a polyethylene-covered Z-stent. Radiology 202:349-354. (Pubitemid 27051724)
8. Watkinson AF, Ellul J, Entwisle K, Mason RC, Adam A. 1995. Esophageal-carcinoma - Initial results of palliative treatment with covered self-expanding endoprostheses. Radiology 195: 821-827.
9. Shields SJ. 1997. Esophageal self-expandable metallic stents. Gastrointest Endosc 45:439-442.
10. Rozanes I, Poyanli A, Acunas B. 2002. Palliative treatment of inoperable malignant esophageal strictures with metal stents: One center's experience with four different stents. Eur J Radiol 43:196-203.
11. Ell C, Hochberger J, May A, Fleig WE, Hahn EG. 1994. Coated and uncoated self-expanding metal stents for malignant stenosis in the upper gi tract - Preliminary clinical-experiences with wallstents. Am J Gastroenterol 89:1496-1500. (Pubitemid 24313040)
12. Oettle H, Arnold D, Kern M, Hoepffner N, Settmacher U, Neuhaus P, Riess H. 2002. Phase I study of gemcitabine in combination with cisplatin, 5-fluorouracil and folinic acid in patients with advanced esophageal cancer. Anti-Cancer Drugs 13:833-838.
13. Ciftci K, Hincal AA, Kas HS, Ercan TM, Sungur A, Guven O, Ruacan S. 1997. Solid tumor chemotherapy and in vivo distribution of fluorouracil following administration in poly(L-lactic acid) microspheres. Pharm Dev Technol 2:151-160.
14. Ajani JA. 1998. Current status of therapy for advanced gastric carcinoma. Oncology 12:99-102. (Pubitemid 28518497)
15. Brierley J, Wong CS, Cummings B, Catton P, Ringash J, Catton C, McLean M, Keane T, Panzarella T. 2001. Squamous cell carcinoma of the oesophagus treated with radiation and 5-fluorouracil, with and without mitomycin C. Clin Oncol 13:157-163.
16. Glickman JN. 2003. Section II: Pathology and pathologic staging of esophageal cancer. Semin Thorac Cardiovasc Surg 15:167-179. (Pubitemid 36874192)
17. Xing DY, Tan W, Lin DX. 2003. Genetic polymorphisms and susceptibility to esophageal cancer among Chinese population (Review). Oncol Rep 10:1615-1623.
18. Allen JW, Richardson JD, Edwards MJ. 1997. Squamous cell carcinoma of the esophagus: A review and update. Surg Oncol 6:193-200.
19. Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, Tanabe L, Kohn KW, Reinhold WC, Myers TG, Andrews DT, Scudiero DA, Eisen MB, Sausville EA, Pommier Y, Botstein D, Brown PO, Weinstein JN. 2000. A gene expression database for the molecular pharmacology of cancer. Nat Genet 24:236-244. (Pubitemid 30132190)
20. Jia WJ, Liu JG, De Zhang Y, Wang JW, Wang J, Sun CY, Pan YF, Yu C, Li GZ, Zhang H, Gou ML, Tu MJ, Qian ZY. 2007. Preparation, characterization, and optimization of pancreas-targeted 5-Fu loaded magnetic bovine serum albumin microspheres. J Drug Target 15:140-145. (Pubitemid 46957700)
21. Grem JL. 1990. Fluorinated pyrimidines. In: Chabner BA, Collins JM, editors. Cancer chemotherapy: Principles and practice. Philadelphia: JB Lippincott Co. pp 180-224.
22. Wei X, Gong C, Shi S, Fu S, Men K, Zeng S, Zheng X, Gou M, Chen L, Qiu L, Qian Z. 2009. Self-assembled honokiol-loaded micelles based on poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) copolymer. Int J Pharm 369:170-175.
23. Daher GC, Harris BE, Diasio RB. 1990. Metabolism of pyrimidine analogs and their nucleosides. Pharmacol Ther 48:189-222.
24. Diasio RB, Harris BE. 1989. Clinical-pharmacology of 5-fluorouracil. Clin Pharmacokinet 16:215-237.
25. Guo QH, Guo SR, Wang ZM. 2007. A type of esophageal stent coating composed of one 5-fluorouracil-containing EVA layer and one drug-free protective layer: In vitro release, permeation and mechanical properties. J Control Release 118:318-324.
26. Guo QH, Guo SR, Wang ZM. 2007. Estimation of 5-fluorouracil-loaded ethylene-vinyl acetate stent coating based on percolation thresholds. Int J Pharm 333:95-102.
27. Langer R, Brem H, Tapper D. 1981. Biocompatibility of polymeric delivery systems for macromolecules. J Biomed Mater Res 15:267-277.
28. Sawyer PN, Page M, Rudewald B, Lagergre H, Baselius L, McCool C, Halperin W, Srinivas S. 1971. Characteristics of human heart - design requirements for replacement. Trans Am Soc Artif Intern Organs 17:470-473.
29. Wang J, Liu C, Lu X, Yin M. 2007. Co-polypeptides of 3,4- dihydroxyphenylalanine and l-lysine to mimic marine adhesive protein. Biomaterials 28:3456-3468. (Pubitemid 46726631)
30. Grem JL, McAtee N, Steinberg SM, Hamilton JM, Murphy RF, Drake J, Chisena T, Balis F, Cysyk R, Arbuck SG, Sorensen JM, Chen AP, Goldstein L, Jordan E, Setser A, Goldspiel B, Decarvalho M, Allegra CJ. 1993. A phase-i study of continuous-infusion 5-fluorouracil plus calcium leucovorin in combination with n-(phosphonacetyl)-l-aspartate in metastatic gastrointestinal adenocarcinoma. Cancer Res 53:4828-4836.
31. Tanaka K, Mohri Y, Ohi M, Yokoe T, Koike Y, Morimoto Y, Miki C, Tonouchi H, Kusunoki M. 2008. Mitotic checkpoint genes, hsMAD2 and BubR1, in oesophageal squamous cancer cells and their association with 5-fluorouracil and cisplatin-based radiochemotherapy. Clin Oncol 20:639-646.
32. Longley DB, Harkin DP, Johnston PG. 2003. 5-Fluorouracil: Mechanisms of action and clinical strategies. Nat Rev Cancer 3:330-338. (Pubitemid 37328853)
33. Baron TH, Burgart LJ, Pochron NL. 2006. An internally covered (lined) self-expanding metal esophageal stent: Tissue response in a porcine model. Gastrointest Endosc 64:263-267.